Martin Fassnacht
Martin Fassnacht
Universitätsklinikum Würzburg
Verified email at medizin.uni-wuerzburg.de
Title
Cited by
Cited by
Year
Adrenocortical carcinoma: clinical update
B Allolio, M Fassnacht
The Journal of Clinical Endocrinology & Metabolism 91 (6), 2027-2037, 2006
8162006
The immune landscape of cancer
V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ...
Immunity 48 (4), 812-830. e14, 2018
7002018
Adjuvant mitotane treatment for adrenocortical carcinoma
M Terzolo, A Angeli, M Fassnacht, F Daffara, L Tauchmanova, PA Conton, ...
New England Journal of Medicine 356 (23), 2372-2380, 2007
6932007
Comprehensive characterization of cancer driver genes and mutations
MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ...
Cell 173 (2), 371-385. e18, 2018
6172018
Management of adrenal incidentalomas: European society of endocrinology clinical practice guideline in collaboration with the European network for the study of adrenal tumors
M Fassnacht, W Arlt, I Bancos, H Dralle, J Newell-Price, A Sahdev, ...
Eur J Endocrinol 175 (2), G1-G34, 2016
5472016
Combination chemotherapy in advanced adrenocortical carcinoma
M Fassnacht, M Terzolo, B Allolio, E Baudin, H Haak, A Berruti, S Welin, ...
New England Journal of Medicine 366 (23), 2189-2197, 2012
5452012
Oncogenic signaling pathways in the cancer genome atlas
F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ...
Cell 173 (2), 321-337. e10, 2018
5042018
Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification
M Fassnacht, S Johanssen, M Quinkler, P Bucsky, HS Willenberg, ...
Cancer 115 (2), 243-250, 2009
4632009
Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer
KA Hoadley, C Yau, T Hinoue, DM Wolf, AJ Lazar, E Drill, R Shen, ...
Cell 173 (2), 291-304. e6, 2018
4462018
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics
J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ...
Cell 173 (2), 400-416. e11, 2018
4142018
Integrated genomic characterization of adrenocortical carcinoma
G Assié, E Letouzé, M Fassnacht, A Jouinot, W Luscap, O Barreau, ...
Nature genetics 46 (6), 607-612, 2014
3832014
Adrenocortical carcinoma: a clinician's update
M Fassnacht, R Libé, M Kroiss, B Allolio
Nature Reviews Endocrinology 7 (6), 323-335, 2011
3552011
Update in adrenocortical carcinoma
M Fassnacht, M Kroiss, B Allolio
The Journal of Clinical Endocrinology & Metabolism 98 (12), 4551-4564, 2013
3252013
Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors
W Arlt, M Biehl, AE Taylor, S Hahner, R Libe, BA Hughes, P Schneider, ...
The Journal of Clinical Endocrinology & Metabolism 96 (12), 3775-3784, 2011
3182011
Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
A Berruti, E Baudin, H Gelderblom, HR Haak, F Porpiglia, M Fassnacht, ...
Annals of oncology 23 (suppl_7), vii131-vii138, 2012
3132012
Clinical management of adrenocortical carcinoma
M Fassnacht, B Allolio
Best practice & research Clinical endocrinology & metabolism 23 (2), 273-289, 2009
2962009
Comprehensive pan-genomic characterization of adrenocortical carcinoma
S Zheng, AD Cherniack, N Dewal, RA Moffitt, L Danilova, BA Murray, ...
Cancer cell 29 (5), 723-736, 2016
2932016
Mutations in the deubiquitinase gene USP8 cause Cushing's disease
M Reincke, S Sbiera, A Hayakawa, M Theodoropoulou, A Osswald, ...
Nature genetics 47 (1), 31-38, 2015
2712015
Management of adrenocortical carcinoma
B Allolio, S Hahner, D Weismann, M Fassnacht
Clinical endocrinology 60 (3), 273-287, 2004
2692004
Constitutive activation of PKA catalytic subunit in adrenal Cushing's syndrome
F Beuschlein, M Fassnacht, G Assié, D Calebiro, CA Stratakis, A Osswald, ...
New England Journal of Medicine 370 (11), 1019-1028, 2014
2632014
The system can't perform the operation now. Try again later.
Articles 1–20